amiodarone has been researched along with Brain Ischemia in 6 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Brain Ischemia: Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the present manuscript we critically review the available evidence for pleiotropic effects of dronedarone in settings of myocardial and cerebral ischemia/reperfusion, both from experimental and clinical data." | 8.88 | Pleiotropic effects of dronedarone on ischemia/reperfusion injury in heart and brain. ( Heusch, G; Schulz, R, 2012) |
| "The amiodarone pre-treatment group received 50 mg/kg of amiodarone 1 h before MCAO; the amiodarone post-treatment groups received 50 mg/kg of amiodarone immediately after MCAO; the control group received vehicle only." | 5.46 | Neuroprotective effects of amiodarone in a mouse model of ischemic stroke. ( Hishiyama, S; Ishiyama, T; Kotoda, M; Matsukawa, T; Mitsui, K, 2017) |
| "In the present manuscript we critically review the available evidence for pleiotropic effects of dronedarone in settings of myocardial and cerebral ischemia/reperfusion, both from experimental and clinical data." | 4.88 | Pleiotropic effects of dronedarone on ischemia/reperfusion injury in heart and brain. ( Heusch, G; Schulz, R, 2012) |
| "propafenone." | 1.91 | Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants. ( Chang, SH; Chen, SW; Huang, CH; Huang, YC; Huang, YT; Hung, KC; Kuo, CF; Tu, HT; Wang, CL; Wu, VC, 2023) |
| "The amiodarone pre-treatment group received 50 mg/kg of amiodarone 1 h before MCAO; the amiodarone post-treatment groups received 50 mg/kg of amiodarone immediately after MCAO; the control group received vehicle only." | 1.46 | Neuroprotective effects of amiodarone in a mouse model of ischemic stroke. ( Hishiyama, S; Ishiyama, T; Kotoda, M; Matsukawa, T; Mitsui, K, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Pallisgaard, J | 1 |
| Greve, AM | 1 |
| Lock-Hansen, M | 1 |
| Thune, JJ | 1 |
| Fosboel, EL | 1 |
| Devereux, RB | 1 |
| Okin, PM | 1 |
| Gislason, GH | 1 |
| Torp-Pedersen, C | 1 |
| Bang, CN | 1 |
| Wu, VC | 1 |
| Wang, CL | 1 |
| Huang, YC | 1 |
| Tu, HT | 1 |
| Huang, YT | 1 |
| Huang, CH | 1 |
| Chen, SW | 1 |
| Kuo, CF | 1 |
| Hung, KC | 1 |
| Chang, SH | 1 |
| Kotoda, M | 1 |
| Ishiyama, T | 1 |
| Mitsui, K | 1 |
| Hishiyama, S | 1 |
| Matsukawa, T | 1 |
| Gil Núñez, A | 1 |
| Heusch, G | 1 |
| Schulz, R | 1 |
| O'Donnell, MJ | 1 |
| Valens, N | 1 |
| Lansberg, MG | 1 |
| Wijman, CA | 1 |
1 review available for amiodarone and Brain Ischemia
| Article | Year |
|---|---|
Pleiotropic effects of dronedarone on ischemia/reperfusion injury in heart and brain.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Brain Ischemia; Dronedarone; Humans; Myocardial Ischemi | 2012 |
5 other studies available for amiodarone and Brain Ischemia
| Article | Year |
|---|---|
Atrial fibrillation onset before heart failure or vice versa: what is worst? A nationwide register study.
Topics: Amiodarone; Anticoagulants; Antihypertensive Agents; Atrial Fibrillation; Brain Ischemia; Heart Fail | 2023 |
Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Brain | 2023 |
Neuroprotective effects of amiodarone in a mouse model of ischemic stroke.
Topics: Amiodarone; Animals; Brain Ischemia; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Neuropr | 2017 |
[Advances in the prevention of cerebral ischaemia due to atrial fibrillation].
Topics: Amiodarone; Anticoagulants; Antifibrinolytic Agents; Atrial Fibrillation; Benzimidazoles; beta-Alani | 2010 |
Thyroid replacement therapy and atrial fibrillation in acute ischemic stroke.
Topics: Acute Disease; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bra | 2006 |